Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
3.930
+0.310 (8.56%)
At close: Jun 15, 2026, 4:00 PM EDT
4.000
+0.070 (1.78%)
After-hours: Jun 15, 2026, 4:17 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $10.41 million as of June 15, 2026. Its market cap has increased by 19.10% in one year.
Market Cap
10.41M
Enterprise Value
-532.23K
1-Year Change
19.10%
Ranking
Category
Stock Price
$3.93
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $10.41M, a decrease of -84.23%. That is a compound annual growth rate of -46.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 10.41M | -57.74% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 10.93M |
| Jupiter Neurosciences | 10.39M |
| BioCardia | 10.01M |
| Kairos Pharma | 9.42M |
| HCW Biologics | 9.17M |
| Curanex Pharmaceuticals | 9.11M |
| MetaVia | 8.99M |
| BioRestorative Therapies | 8.98M |